Exosomes derived from renal cell carcinoma have been shown to contain TGF-β1 and transfer it to tumor-infiltrating natural killer cells, impairing their functioning through activation of the TGF-β/SMAD pathway [105]. The gene discussed is TGFB1; the disease is neoplasm.